Thera Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 84.69%
(FY 2022)
- Ebitda 86.82%
(FY 2022)
- Net Worth -29.90%
(FY 2022)
- Total Assets 0.59%
(FY 2022)
About Thera Nutraceuticals
The Corporate was formerly known as Thera Neutracuticals Private Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnasamy Dhanakumar and Sivasubraman Mukunthakumar serve as directors at the Company.
- CIN/LLPIN
U74999TZ2018PTC031358
- Company No.
031358
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2018
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Thera Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnasamy Dhanakumar  | Director | 12-Dec-2018 | Current |
| Sivasubraman Mukunthakumar | Director | 21-Feb-2022 | Current |
Financial Performance of Thera Nutraceuticals.
Thera Nutraceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 84.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thera Nutraceuticals?
Unlock access to Thera Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Foundation One Infrastructures Private LimitedActive 17 years 19 daysKrishnasamy Dhanakumar is a mutual person
The White Horse Distilleries Private LimitedActive 23 years 1 monthKrishnasamy Dhanakumar is a mutual person
- Sri Arumuga Cottspin Private LimitedActive 20 years 7 months
Krishnasamy Dhanakumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Thera Nutraceuticals?
Unlock and access historical data on people associated with Thera Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thera Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thera Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
